First presentation of data from Phase 3 KRYSTAL-12 study showed statistically significant and clinically meaningful improvement in progression-free survival with KRAZATI compared to standard of care.
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Metastatic Breast Cancer Pipeline Outlook, FDA Approvals, Clinical Trials And Companies 2024 (Updated) menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Performance Reflects Execution and Actions to Strengthen the Company s Long-Term Growth Profile
First Quarter Revenues were $11.9 Billion, increasing 5%
Growth Portfolio Revenues were $4.8.
Bristol Myers Beats on Revenue as Revlimid Sales Decline Slows bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.